Welcome Ljubljana - the Host City General Information Key Dates and Deadlines Local Organizing Committee Scientific Programme Scientific Programme Topics Scientific Programme Committee Proceedings Photos from Meeting Sponsors & Exhibition		SUMMARY - POSTER SESSIONS Monday - Tuesday - Wednesday - Thursday - Friday Click on day name to see detailed programme. Tuesday  August 29  Cankarjev Dom Congress Centre 08.30-19.30  Registration 08.30-19.30  Poster Display 08.30-19.30  Trade Display 08.30-09.45  ORAL SESSION – WORKPLACE DRUG TESTING & DOPING CONTROL Chairpersons: Dr Anya Pierce, Dr John Lewis WD-o-01  Psychotropic Side-Effects of Anabolic Steroids CM Müller-Platz1, RK Müller2, H. Michna3 1Federal Institute of Sports Science, Bonn; 2Institute of Doping Analysis and Sportsbiochemistry, Dresden; 3Institute of Public Health Research, Technical University Munich, Germany WD-o-02  Analysis of Anabolic Steroids in Urine by LC/MS/MS Michael C. Zumwalt1, John M. Hughes1, Matthew H. Slawson2, Chad R. Borges2 and Dennis J. Crouch2 1Agilent Technologies, Englewood, MS; 2Center for Human Toxicology, University of Utah, USA 15 min WD-o-03  Determination of Opiates, Amphetamines, Cocaine, Phencyclidine, and Metabolites in Hair by LC-MS-MS Min-Kun Huang, Choung-Huei Lee, Chiareiy Liu, Chun-Sheng Chien National Bureau of Controlled Drugs, DOH, Taiwan, ROC WD-o-04  Overview of the situation of workplace drug testing in Europe Alain G Verstraete Laboratory of Clinical Biology–Toxicology, Ghent University Hospital, and Department of Clinical Biology, Microbiology and Immunology, Ghent University, Belgium WD-o-05  WORKPLACE DRUG TESTING: THREE YEARS EXPERIENCE IN THE FINNISH DEFENSE FORCES Sirpa Mykkänen1, Pirjo Lillsunde1, Esa Meririnne2, Kyösti Lehtomäki2, Markus Henriksson1 1National Public Health Institute, Laboratory of Alcohol and Substance Abuse, Helsinki, Finland; 2Centre for Military Medicine, Finnish Defense Forces, Lahti, Finland WD-o-06  Presence of THC-COOH in urine after drinking "Cannabis-beer" Olof M.L.Beck1, Mats Brunes2, Michael Boettcher3 1Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden; 2Dependence Clinic, Karolinska Hospital, Stockholm, Sweden; 3Arxtpraxis f. Med. Mikrobiol., Dessau, Germany 09.45-10.05  Coffee Break 10.05-11.20  ORAL SESSION – BEHAVIORAL TOXICOLOGY Chairpersons: Dr Marilyn Huestis, Prof. Manfred Moeller BT-o-01  Prevalence of alcohol and illegal drugs in blood samples from drivers involved in traffic law violations: systematic review of the literature Leonardo González Wilhelm1,2 1Center of Forensic Medicine, J.W. Goethe University, Frankfurt/Main, Germany; 2CIGES (Center of Training, Research and Management for Evidence-Based Health), Faculty of Medicine, Universidad de La Frontera, Temuco, Chile BT-o-02  Cannabis and driving: results from a general population survey F. Javier Álvarez, Inmaculada Fierro and M. Carmen del Río Department of Pharmacology, Institute for Alcohol and Drug Studies, Faculty of Medicine, University of Valladolid, Spain BT-o-03  Application of models for the prediction of time of marijuana exposure from blood of drivers arrested for DUI Ann Marie Gordon, Rodney Gullberg and Barry K. Logan Washington State Toxicology Laboratory, Seattle, WA, USA BT-o-04  Age- and sex-related differences in blood- amphetamine concentrations in DUID suspects and reflections on drug- related impairment Alan Wayne Jones Department of Forensic Chemistry, Linköping, Sweden BT-o-05  Driving Impairment from Dextromethorphan Abuse Barry K. Logan1 and Chuck Hayes2 1Washington State Toxicology Laboratory, Seattle, WA, USA; 2IACP/DRE, Salem, OR, USA BT-o-06  Risk of involvement in traffic accidents associated with the prescription of medicinal drugs: A registry-based cohort study J. Mørland, S. Skurtveit and A. Engeland Norwegian Institute of Public health, Oslo, Norway 11.20-11.40  Coffee Break 11.40-13.00  ORAL SESSION – ALTERNATIVE SPECIMENS I Chairpersons: Dr Edward Cone, Prof. Alain Verstraete AS-o-01  Drugs in oral fluid in randomly selected drivers Olaf H. Drummer, D. Gerostamoulos and M. Chu Forensic and Scientific Services, Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, Melbourne, Australia 15 min AS-o-02  Analysis of paired blood and oral fluid specimens from randomly selected nighttime drivers Christine Moore1, John Lacey2 , Tara Kelley-Baker2, Cynthia Coulter1, Katharine Brainard2 , Debra Furr-Holden2, Sumandeep Rana1 and Michael Vincent1 1Immunalysis Corporation, 829 Towne Center Drive, Pomona, California 91767; 2Pacific Institute for Research & Evaluation, 11710 Beltsville Drive, Calverton, Maryland, 20705,USA 15 min AS-o-03  Roadside drug testing in oral fluid – the Saarland experience Thomas Kraemer1, Katrin Ettmueller1, Eva Prinz1, Hans-Juergen Maurer2 and Jochen Wilske1 1Institute of Legal Medicine, Saarland University, Homburg, Germany; 2Saarland State Police Department, Saarbruecken, Germany AS-o-04  Confirmation by LC-MS of drugs in oral fluid obtained from Roadside testing M. Concheiro, A. de Castro, O. Quintela, A. Cruz and M. López-Rivadulla. Forensic Toxicology Service. Institute of Legal Medicine. University of Santiago of Compostela. Spain AS-o-05  Use of oral fluid drug tests at the roadside: the results of the Rosita-2 study A.Verstraete1, E. Raes2 1Laboratory of Clinical Biology–Toxicology, Ghent University Hospital; 2Department of Clinical Biology, Microbiology and Immunology, Ghent University, Belgium AS-o-06  An evaluation of five rapid oral fluid drug-testing devices Maria Kala, Wojciech Lechowicz, Piotr Adamowicz, Ewa Chudzikiewicz, Ewa Janowska and Maciej Kochanowski Institute of Forensic Research in Krakow, Poland 13.00-14.00  Lunch Break 14.15-15.30  ORAL SESSION – ALTERNATIVE SPECIMENS II Chairpersons: Dr Vina Spiehler, Prof. Thomas Daldrup AS-o-07  Development and validation of the Cozart® DDS Oral Fluid Collection Device T. Speedy, D. Baldwin, G. Jowett, M. Gallina and A. Jehanli Cozart Bioscience Ltd, Abingdon, Oxfordshire, England AS-o-08  The recovery of illicit drugs from oral fluid sampling devices Susan Nolan Institute of Environmental Science and Research Limited, New Zealand AS-o-09  Simultaneous determination of 6 amphetamines and analogues in hair and urine by LC-ESI-MS/MS: Application to the determination of MDMA after the absorption of a single dose of “Ecstasy” M. Chèze, M. Deveaux and G. Pépin Laboratoire TOXLAB, Paris, France AS-o-10  Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan® and Valium® Marleen Laloup1, Maria del Mar Ramirez Fernandez1, Michelle Wood2, Gert De Boeck1, Viviane Maes3, Nele Samyn1 1National Institute of Criminalistics and Criminology; 2Waters Corporation; 3Academic Hospital AZ-VUB, Belgium AS-o-11  Applications of arsenic speciation by HPLC-ICP/MS P. Kintz, N. Marques, M. Ginet and V. Cirimele Laboratoire ChemTox, Illkirch, France AS-o-12  Ecstasy (MDMA) detected in 3 years old semen stains in a case of sexual assault Peter X. Iten and Maja Zaugg Institute of Legal Medicine, Dept. of Forensic Toxicology, Zurich, Switzerland 15.30-16.00  Coffee Break 15.30-19.30  Poster Session 17.00-19.00  ROUND TABLE: Drugs and driving Chairpersons: Prof. Olaf Drummer, Prof. J. Mørland 16.00-18.00  Agilent Technologies seminar (Conference room M1-2) 18.00-19.30  Randox seminar (Conference room M1-2) 17.30-19.30  Waters Corporation seminar (Conference room M3-4) 20.00-21.00  Concert (St.Jakob Church), Free evening in the Old town of Ljubljana Top

Contacts | www.tiaft.org PLATINUM SPONSOR: Agilent Technologies © 2006 Institute of Forensic Medicine, Ljubljana. All rights reserved.